antipyrine has been researched along with Granuloma, Hodgkin in 4 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Excerpt | Relevance | Reference |
---|---|---|
" It should be taken into account when dosing drugs which are metabolized as markers of the liver metabolic efficiency like phenazone and sulphadimidine." | 2.68 | [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms]. ( Kotlarek-Haus, S; Milejski, P; Orzechowska-Juzwenko, K; Urbaniak-Kujda, D; Usnarska-Zubkiewicz, L; Wiela-Hojeńska, A, 1997) |
" The mean phenazone half-life (t0." | 1.27 | Phenazone pharmacokinetics as an index of hepatic metabolic efficiency. ( Kotlarek-Haus, S; Orzechowska-Juzwenko, K; Plamieniak, B; Wiela, A; Wolowiec, D, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SVIRCEVIC, A | 1 |
TEPAVCEVIC, P | 1 |
KOVAC, T | 1 |
Wiela-Hojeńska, A | 1 |
Milejski, P | 1 |
Orzechowska-Juzwenko, K | 2 |
Usnarska-Zubkiewicz, L | 1 |
Urbaniak-Kujda, D | 1 |
Kotlarek-Haus, S | 2 |
Wiela, A | 1 |
Plamieniak, B | 1 |
Wolowiec, D | 1 |
Juma, FD | 1 |
1 trial available for antipyrine and Granuloma, Hodgkin
Article | Year |
---|---|
[Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
Topics: Acetylation; Adolescent; Adult; Aged; Antipyrine; Disease Susceptibility; Female; Hodgkin Disease; H | 1997 |
3 other studies available for antipyrine and Granuloma, Hodgkin
Article | Year |
---|---|
[EXPERIENCES IN THE USE OF AVAFORTAN, A SPASMO-ANALGESIC AGENT].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Biliary Dyskinesia; Cholecystitis; C | 1965 |
Phenazone pharmacokinetics as an index of hepatic metabolic efficiency.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Female; Hodgkin Disease; Humans; | 1988 |
Disposition of antipyrine in African patients with Hodgkin's lymphoma.
Topics: Adult; Antipyrine; Female; Half-Life; Hodgkin Disease; Humans; Kenya; Male | 1987 |